Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies.
Dragoni F, Schiaroli E, Micheli V, Fiaschi L, Lai A, Zehender G, Rossetti B, Gismondo MR, Francisci D, Zazzi M, Vicenti I. Dragoni F, et al. Among authors: fiaschi l. Clin Microbiol Infect. 2022 Jul;28(7):1037-1039. doi: 10.1016/j.cmi.2022.03.005. Epub 2022 Mar 15. Clin Microbiol Infect. 2022. PMID: 35304279 Free PMC article. No abstract available.
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination.
Varasi I, Lai A, Fiaschi L, Bergna A, Gatti A, Caimi B, Biba C, Della Ventura C, Balotta C, Riva A, Zehender G, Zazzi M, Vicenti I. Varasi I, et al. Among authors: fiaschi l. J Infect. 2023 Sep;87(3):270-272. doi: 10.1016/j.jinf.2023.06.019. Epub 2023 Jun 30. J Infect. 2023. PMID: 37394012 No abstract available.
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses.
Parisi SG, Mengoli C, Basso M, Vicenti I, Gatti F, Scaggiante R, Fiaschi L, Giammarino F, Iannetta M, Malagnino V, Zago D, Dragoni F, Zazzi M. Parisi SG, et al. Among authors: fiaschi l. Vaccines (Basel). 2022 Aug 2;10(8):1237. doi: 10.3390/vaccines10081237. Vaccines (Basel). 2022. PMID: 36016125 Free PMC article.
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy.
Vicenti I, Basso M, Pirola N, Bragato B, Rossi MC, Giobbia M, Pascoli S, Vinci A, Caputo S, Varasi I, Biba C, Fiaschi L, Zazzi M, Parisi SG. Vicenti I, et al. Among authors: fiaschi l. Vaccines (Basel). 2023 Apr 20;11(4):871. doi: 10.3390/vaccines11040871. Vaccines (Basel). 2023. PMID: 37112782 Free PMC article.